Aardvark Therapeutics (AARD) vs Quantum Cyber N.V. (QUCY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Quantum Cyber N.V. (QUCY) has outperformed Aardvark Therapeutics (AARD) over the past year, losing 13.3% versus a loss of 71.5%. Quantum Cyber N.V. is the larger company by market cap ($118.1 million vs $106.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AARD | QUCY |
|---|---|---|
| Share price | $4.85 | $1.41 |
| Market cap | $106.14M | $118.12M |
| 1-day change | -2.22% | -1.75% |
| YTD return | -62.21% | +27.68% |
| 1-year return | -71.51% | -13.33% |
| EPS (TTM) | $-3.21 | $-2.41 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.23 | $4.93 |
| 52-week low | $3.35 | $0.30 |
| Distance from 52-week high | -71.84% | -71.50% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +540.57% |
| Average volume | 209.46K | 701.66K |
| Shares outstanding | 21.88M | 84.07M |
| Employees | — | 10 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- QUCY has outperformed AARD by 58.2 percentage points over the past year.
About Quantum Cyber N.V.
QUCY stock →Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions.
Health Care · Biotechnology: Pharmaceutical Preparations · 10 employees
AARD vs QUCY FAQ
Which is bigger, Aardvark Therapeutics or Quantum Cyber N.V.?
Quantum Cyber N.V. (QUCY) is larger, with a market capitalization of $118.12M compared with $106.14M for Aardvark Therapeutics (AARD).
Which stock has performed better over the past year, AARD or QUCY?
QUCY returned -13.33% over the past 12 months, compared with -71.51% for AARD (price return, excluding dividends). Past performance does not predict future results.
Are Aardvark Therapeutics and Quantum Cyber N.V. in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.